Marie L. De Bruin

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey.

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey.

Journal: British journal of clinical pharmacology

Published: June 22, 2026

Dispensing of benzodiazepines and benzodiazepine-related drugs in Estonia, Latvia and Lithuania: a cross-national drug utilisation study.

Dispensing of benzodiazepines and benzodiazepine-related drugs in Estonia, Latvia and Lithuania: a cross-national drug utilisation study.

Journal: Nordic journal of psychiatry

Published: May 20, 2026

Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligence.

Text mining methods for automated data extraction from health technology assessment reports of medicines using classical natural language processing and generative artificial intelligence.

Journal: JAMIA open

Published: October 21, 2025

Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literature.

Gaining regulatory acceptance for novel technologies in nonclinical drug development: A scoping review of its conceptualization in scientific literature.

Journal: Drug discovery today

Published: October 14, 2025

Through the lens of marketing authorization holders: experience in use of real-world data and real-world evidence in drug development and regulatory submissions in EU.

Through the lens of marketing authorization holders: experience in use of real-world data and real-world evidence in drug development and regulatory submissions in EU.

Journal: British journal of clinical pharmacology

Published: September 21, 2025

Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis.

Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis.

Journal: European journal of clinical pharmacology

Published: July 22, 2025

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase.

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase.

Journal: British journal of clinical pharmacology

Published: May 09, 2025

Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in Europe.

Decoding RNA regulation: Challenges and opportunities for RNA-based therapies in Europe.

Journal: British journal of clinical pharmacology

Published: May 05, 2025

Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study.

Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study.

Journal: Drug safety

Published: March 31, 2025

Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revision.

Innovative industry perspective: Assessing the proposed regulatory changes and their impact on innovation and competitiveness of the EU regulatory framework as part of the EU General Pharmaceutical Legislation revision.

Journal: Drug discovery today

Published: October 20, 2024

Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.

Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies.

Journal: Clinical pharmacology and therapeutics

Published: September 13, 2024

Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study.

Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study.

Journal: Vaccine

Published: February 01, 2024

Showing 1-12 of 132

Last Updated: 09/26/2026